Quarterly report pursuant to Section 13 or 15(d)

Share-based compensation

v3.21.1
Share-based compensation
3 Months Ended
Mar. 31, 2021
Share-based compensation  
Share-based compensation

Note 11 Share-based compensation

The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):

Three months ended

March 31, 

    

2021

    

2020

Research and development

$

2,375

$

978

General and administrative

 

2,959

470

$

5,334

$

1,448

The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:

Three months ended

March 31, 

    

2021

    

2020

Number of options over ordinary shares granted

14,803,056

10,229,280

Weighted average fair value of ordinary shares options

$

0.75

$

0.51

Number of additional options with a nominal exercise price granted

12,663,792

6,060,696

Weighted average fair value of options with a nominal exercise price

$

1.03

$

0.74